Aeglea BioTherapeutics, Inc. (21) | License Agreements (2)
- License and Supply Agreement, dated March 21, 2021, by and between the Registrant and Immedica Pharma AB (Filed With SEC on May 10, 2021)
- Amended and Restated Patent License Agreement No. PM1401501, dated January 31, 2017, between the Registrant and The University of Texas at Austin on behalf of the Board of Regents... (Filed With SEC on March 7, 2019)
